AAAAAA

   
Results: 1-24 |
Results: 24
BONE REMODELING AND MACROPHAGE DIFFERENTIATION IN OSTEOPETROSIS (OP) MUTANT MICE DEFECTIVE IN THE PRODUCTION OF MACROPHAGE-COLONY-STIMULATING FACTOR
Authors: TAKATSUKA H UMEZU H HASEGAWA G USUDA H EBE Y NAITO M SHULTZ LD
Citation: H. Takatsuka et al., BONE REMODELING AND MACROPHAGE DIFFERENTIATION IN OSTEOPETROSIS (OP) MUTANT MICE DEFECTIVE IN THE PRODUCTION OF MACROPHAGE-COLONY-STIMULATING FACTOR, Journal of submicroscopic cytology and pathology, 30(2), 1998, pp. 239-247
IMMUNOCHEMICAL QUANTIFICATION OF CROSSLINE AS A FLUORESCENT ADVANCED GLYCATION ENDPRODUCT IN ERYTHROCYTE-MEMBRANE PROTEINS FROM DIABETIC-PATIENTS WITH OR WITHOUT RETINOPATHY
Authors: YAMAGUCHI M NAKAMURA N NAKANO K KITAGAWA Y SHIGETA H HASEGAWA G IENAGA K NAKAMURA K NAKAZAWA Y FUKUI I OBAYASHI H KONDO M
Citation: M. Yamaguchi et al., IMMUNOCHEMICAL QUANTIFICATION OF CROSSLINE AS A FLUORESCENT ADVANCED GLYCATION ENDPRODUCT IN ERYTHROCYTE-MEMBRANE PROTEINS FROM DIABETIC-PATIENTS WITH OR WITHOUT RETINOPATHY, Diabetic medicine, 15(6), 1998, pp. 458-462
HYPERTROPHIC CARDIOMYOPATHY WITH TYPE-I CD36 DEFICIENCY
Authors: WATANABE K TOBA K OGAWA Y KODAMA M HIRONO S OHKURA Y HANAWA H NAKAMURA Y AOKI Y FUSE I AIZAWA Y MIYAJIMA S KUSANO Y NAGATOMO T HASEGAWA G NAITO M
Citation: K. Watanabe et al., HYPERTROPHIC CARDIOMYOPATHY WITH TYPE-I CD36 DEFICIENCY, Japanese Circulation Journal, 62(7), 1998, pp. 541-542
NEW DEVELOPMENT OF RESOLVING AGENTS FOR INDUSTRIAL PURPOSES
Authors: HASEGAWA G MIURA T WATADANI T HONG N
Citation: G. Hasegawa et al., NEW DEVELOPMENT OF RESOLVING AGENTS FOR INDUSTRIAL PURPOSES, Yuki Gosei Kagaku Kyokaishi, 56(9), 1998, pp. 773-780
ALDOSE REDUCTASE IN PERIPHERAL MONONUCLEAR-CELLS FROM NIDDM PATIENTS
Authors: HASEGAWA G KIMURA F YAMAGUCI M HIRATA C SHIGETA H NAKAMURA N NAKANO K KONDO M OBAYASHI H KITAGAWA Y NISHIMURA CY
Citation: G. Hasegawa et al., ALDOSE REDUCTASE IN PERIPHERAL MONONUCLEAR-CELLS FROM NIDDM PATIENTS, Diabetes, 47, 1998, pp. 546-546
CROSSLINE, ONE OF MAJOR AGES, LEVELS IN SERUM AND ERYTHROCYTE-MEMBRANE PROTEINS ARE ELEVATED IN NIDDM PATIENTS WITH NEPHROPATHY
Authors: FUJII M OBAYASHI H MORIWAKI A FUKUI M YOSHIMORI K HASEGAWA G SHIGETA H KITAGAWA Y NAKAMURA N NAKANO K KONDO M
Citation: M. Fujii et al., CROSSLINE, ONE OF MAJOR AGES, LEVELS IN SERUM AND ERYTHROCYTE-MEMBRANE PROTEINS ARE ELEVATED IN NIDDM PATIENTS WITH NEPHROPATHY, Diabetes, 47, 1998, pp. 1439-1439
DEVELOPMENT, DIFFERENTIATION, AND MATURATION OF KUPFFER CELLS
Authors: NAITO M HASEGAWA G TAKAHASHI K
Citation: M. Naito et al., DEVELOPMENT, DIFFERENTIATION, AND MATURATION OF KUPFFER CELLS, Microscopy research and technique, 39(4), 1997, pp. 350-364
PERFORMANCE IMPROVEMENT OF TCP OVER EFCI-BASED ABR SERVICE CLASS BY TUNING OF CONGESTION CONTROL PARAMETERS
Authors: HASEGAWA G OHSAKI H MURATA M MIYAHARA H
Citation: G. Hasegawa et al., PERFORMANCE IMPROVEMENT OF TCP OVER EFCI-BASED ABR SERVICE CLASS BY TUNING OF CONGESTION CONTROL PARAMETERS, IEICE transactions on communications, E80B(10), 1997, pp. 1444-1453
SERUM AUTOANTIBODIES AGAINST SULFATIDE AND PHOSPHOLIPID IN NIDDM PATIENTS WITH DIABETIC NEUROPATHY
Authors: SHIGETA H YAMAGUCHI M NAKANO K OBAYASHI H TAKEMURA R FUKUI M FUJII M YOSHIMORI K HASEGAWA G NAKAMURA N KITAGAWA Y KONDO M
Citation: H. Shigeta et al., SERUM AUTOANTIBODIES AGAINST SULFATIDE AND PHOSPHOLIPID IN NIDDM PATIENTS WITH DIABETIC NEUROPATHY, Diabetes care, 20(12), 1997, pp. 1896-1899
PRELIMINARY-REPORT - TROGLITAZONE (CS-045) AMELIORATES ALBUMINURIA INSTREPTOZOTOCIN-INDUCED DIABETIC RATS
Authors: FUJII M TAKEMURA R YAMAGUCHI M HASEGAWA G SHIGETA H NAKANO K KONDO M
Citation: M. Fujii et al., PRELIMINARY-REPORT - TROGLITAZONE (CS-045) AMELIORATES ALBUMINURIA INSTREPTOZOTOCIN-INDUCED DIABETIC RATS, Metabolism, clinical and experimental, 46(9), 1997, pp. 981-983
QUANTIFICATION OF CROSSLINE(TM) IN SERUM AND ERYTHROCYTE-MEMBRANE PROTEIN IN DIABETIC SUBJECTS
Authors: YAMAGUCHI M NAKANO K HASEGAWA G SHIGETA H KITAGAWA Y NAKAMURA N OBAYASHI H FUKUI I KONDO M IENAGA K
Citation: M. Yamaguchi et al., QUANTIFICATION OF CROSSLINE(TM) IN SERUM AND ERYTHROCYTE-MEMBRANE PROTEIN IN DIABETIC SUBJECTS, Diabetologia, 40, 1997, pp. 2322-2322
ADVANCED GLYCATION ENDPRODUCTS (AGES) ACCELERATE ANGIOGENESIS INDUCEDBY ANGIOGENIC GROWTH-FACTORS
Authors: FUJII M HASEGAWA G YOSHIMORI K FUKUI M SHIGETA H NAKANO K KONDO M
Citation: M. Fujii et al., ADVANCED GLYCATION ENDPRODUCTS (AGES) ACCELERATE ANGIOGENESIS INDUCEDBY ANGIOGENIC GROWTH-FACTORS, Diabetes, 46, 1997, pp. 501-501
QUANTIFICATION OF CROSSLINE(TM) IN SERUM AND ERYTHROCYTE-MEMBRANE PROTEIN IN DIABETIC SUBJECTS
Authors: NAKANO K HASEGAWA G YAMAGUCHI M IENAGA K NAKAZAWA Y OBAYASHI H FUKUI I KONDO M
Citation: K. Nakano et al., QUANTIFICATION OF CROSSLINE(TM) IN SERUM AND ERYTHROCYTE-MEMBRANE PROTEIN IN DIABETIC SUBJECTS, Diabetes, 46, 1997, pp. 1218-1218
ADVANCED GLYCATION END-PRODUCTS INDUCE EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR BY RETINAL MULLER CELLS
Authors: HIRATA C NAKANO K NAKAMURA N KITAGAWA Y SHIGETA H HASEGAWA G OGATA M IKEDA T SAWA H NAKAMURA K IENAGA K OBAYASHI H KONDO M
Citation: C. Hirata et al., ADVANCED GLYCATION END-PRODUCTS INDUCE EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR BY RETINAL MULLER CELLS, Biochemical and biophysical research communications, 236(3), 1997, pp. 712-715
PERFORMANCE EVALUATION AND PARAMETER TUNING OF TCP OVER ABR SERVICE IN ATM NETWORKS
Authors: HASEGAWA G OHSAKI H MURATA M MIYAHARA H
Citation: G. Hasegawa et al., PERFORMANCE EVALUATION AND PARAMETER TUNING OF TCP OVER ABR SERVICE IN ATM NETWORKS, IEICE transactions on communications, E79B(5), 1996, pp. 668-683
DEVELOPMENT, DIFFERENTIATION, AND PHENOTYPIC HETEROGENEITY OF MURINE TISSUE MACROPHAGES
Authors: NAITO M UMEDA S YAMAMOTO T MORIYAMA H UMEZU H HASEGAWA G USUDA H SHULTZ LD TAKAHASHI K
Citation: M. Naito et al., DEVELOPMENT, DIFFERENTIATION, AND PHENOTYPIC HETEROGENEITY OF MURINE TISSUE MACROPHAGES, Journal of leukocyte biology, 59(2), 1996, pp. 133-138
CROSSLINE-LIKE STRUCTURE ACCUMULATES AS FLUORESCENT ADVANCED GLYCATION END-PRODUCTS IN RENAL TISSUES OF RATS WITH DIABETIC NEPHROPATHY
Authors: IENAGA K KAKITA H HOCHI T NAKAMURA K NAKAZAWA Y FUKUNAGA Y AOKI S HASEGAWA G TSUTSUMI Y KITAGAWA Y NAKANO K
Citation: K. Ienaga et al., CROSSLINE-LIKE STRUCTURE ACCUMULATES AS FLUORESCENT ADVANCED GLYCATION END-PRODUCTS IN RENAL TISSUES OF RATS WITH DIABETIC NEPHROPATHY, Proceedings of the Japan Academy. Series B Physical and biological sciences, 72(4), 1996, pp. 79-84
DIABETIC RENAL-FAILURE AND SERUM ACCUMULATION OF THE CREATININE OXIDATIVE METABOLITES CREATOL AND METHYLGUANIDINE
Authors: NAKAMURA K IENAGA K NAKANO K NAKAI M NAKAMURA Y HASEGAWA G SAWADA M KONDO M MORI H KANATSUNA T
Citation: K. Nakamura et al., DIABETIC RENAL-FAILURE AND SERUM ACCUMULATION OF THE CREATININE OXIDATIVE METABOLITES CREATOL AND METHYLGUANIDINE, Nephron, 73(4), 1996, pp. 520-525
ROLE OF TNF AND IL-1 IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY
Authors: HASEGAWA G NAKANO K KONDO M
Citation: G. Hasegawa et al., ROLE OF TNF AND IL-1 IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY, Nefrologia, 15(1), 1995, pp. 1-4
MATRIX NONENZYMATIC GLYCOSYLATION LEADS TO ALTERED CELLULAR PHENOTYPEAND INTRACELLULAR TYROSINE PHOSPHORYLATIONS
Authors: HASEGAWA G HUNTER AJ CHARONIS AS
Citation: G. Hasegawa et al., MATRIX NONENZYMATIC GLYCOSYLATION LEADS TO ALTERED CELLULAR PHENOTYPEAND INTRACELLULAR TYROSINE PHOSPHORYLATIONS, The Journal of biological chemistry, 270(7), 1995, pp. 3278-3283
EFFECT OF GLUCOSE GLYCATION ON MESANGIAL CELL EXPRESSION OF GENES RELATED TO THE MESANGIAL MATRIX
Authors: ANDERSON S WU K HASEGAWA G SETTY S KIM Y NAGASE H REICHARDT L STETLERSTEVENSON W TSILIBARY E
Citation: S. Anderson et al., EFFECT OF GLUCOSE GLYCATION ON MESANGIAL CELL EXPRESSION OF GENES RELATED TO THE MESANGIAL MATRIX, Journal of the American Society of Nephrology, 5(3), 1994, pp. 960-960
EFFECTS OF ALDEHYDE-MODIFIED PROTEINS ON MESANGIAL CELL-MATRIX INTERACTION
Authors: HASEGAWA G NAKANO K TSUTSUMI Y KONDO M
Citation: G. Hasegawa et al., EFFECTS OF ALDEHYDE-MODIFIED PROTEINS ON MESANGIAL CELL-MATRIX INTERACTION, Diabetes research and clinical practice, 23(1), 1994, pp. 25-32
CREATOL, A CREATININE METABOLITE, AS A USEFUL DETERMINANT OF RENAL-FUNCTION
Authors: NAKAMURA K IENAGA K NAKAI M NAKAMURA Y HASEGAWA G KONDO M MORI H KANATSUNA T SAWADA M NAKANO K
Citation: K. Nakamura et al., CREATOL, A CREATININE METABOLITE, AS A USEFUL DETERMINANT OF RENAL-FUNCTION, Nephron, 66(2), 1994, pp. 140-146
MATRIX NONENZYMATIC GLYCOSYLATION LEADS TO ALTERED CELLULAR PHENOTYPEAND SIGNAL-TRANSDUCTION
Authors: HASEGAWA G HUNTER A CHARONIS AS
Citation: G. Hasegawa et al., MATRIX NONENZYMATIC GLYCOSYLATION LEADS TO ALTERED CELLULAR PHENOTYPEAND SIGNAL-TRANSDUCTION, Diabetes, 43, 1994, pp. 10000096-10000096
Risultati: 1-24 |